Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Recent studies have suggested a bacterial role in the development of autoimmune disorders including type 1 diabetes (T1D). Over 30 billion nucleotide bases of Illumina shotgun metagenomic data were analyzed from stool samples collected from four pairs of matched T1D case-control subjects collected at the time of the development of T1D associated autoimmunity (i.e., autoantibodies). From these, approximately one million open reading frames were predicted and compared to the SEED protein database. Of the 3,849 functions identified in these samples, 144 and 797 were statistically more prevalent in cases and controls, respectively. Genes involved in carbohydrate metabolism, adhesions, motility, phages, prophages, sulfur metabolism, and stress responses were more abundant in cases while genes with roles in DNA and protein metabolism, aerobic respiration, and amino acid synthesis were more common in controls. These data suggest that increased adhesion and flagella synthesis in autoimmune subjects may be involved in triggering a T1D associated autoimmune response. Extensive differences in metabolic potential indicate that autoimmune subjects have a functionally aberrant microbiome. Mining 16S rRNA data from these datasets showed a higher proportion of butyrate-producing and mucin-degrading bacteria in controls compared to cases, while those bacteria that produce short chain fatty acids other than butyrate were higher in cases. Thus, a key rate-limiting step in butyrate synthesis is more abundant in controls. These data suggest that a consortium of lactate- and butyrate-producing bacteria in a healthy gut induce a sufficient amount of mucin synthesis to maintain gut integrity. In contrast, non-butyrate-producing lactate-utilizing bacteria prevent optimal mucin synthesis, as identified in autoimmune subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent findings linked an aberrant microbiome, which is generally represented by diminished diversity, including fewer butyrate-producing (butyrate was shown to trigger mucin production and hence gut integrity) and mucin-degrading bacteria,241 to the development of autoimmunity in T1DM.242”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [241]
The cited source says what the claim attributes to it.
In the citing paper
“The authors further indicate that a decrease in Prevotella might be related with a reduction in mucin synthesis which is associated with increased gut permeability (Brown et al., 2011;Forsyth et al., 2011) intensifying the translocation of bacterial antigens.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Abnormalities of GI motility might increase the occurrence of SIBO which is highly prevalent in PD patients (Brown et al., 2011;Sánchez-Ferro et al., 2015), even in recently diagnosed PD patients (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Experimental — accuracy not yet measuredIn the citing paper
“As mentioned before, SIBO is highly prevalent in PD (Andrews et al., 2009;Brown et al., 2011) and PD patients that tested positive for SIBO are predisposed to worse motordysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 3×
“At the phylum level and at p-values less than 0.001, Actinobacteria, Bacteroidetes, and Proteobacteria were higher in cases while Firmicutes, Fusobacteria, Tenericutes, and Verrucomicrobia were higher in controls.”
BackgroundInfluentialGeneralized, Linear, and Mixed Models
McCulloch, C. E., & Searle, S. R. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/0471722073 · Cited by 2,994
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundThe Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundPeng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 2×
“Perspective signatures of increased mucin synthesis in the gut may be the presence of Prevotella and Akkermansia as both genera are known to degrade mucin [30,39].”
BackgroundInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921 · cited 2×
“Intestinal microbes and the innate immune system also interact to affect the development of diabetes in NOD mice [15].”
Background
Cited by
Items 301–400 of 777
Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives
Kornum, D. S., Terkelsen, A. J., Bertoli, D., Klinge, M. W., Høyer, K. L., Kufaishi, H. H. A., Borghammer, P., Drewes, A. M., Brock, C., & Krogh, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071392 · Cited by 47
“However, prokinetic treat-ment has major limitations, especially the risk of extrapyramidal side effects including potentially irreversible tardive dyskinesia (metoclopramide), drug-induced arrhythmias (domperidone), and lack of evidence for long-term effectiveness [177,178].”
BackgroundImplications of Gut Microbiota in Complex Human Diseases
Yu, D., Meng, X., de Vos, W. M., Wu, H., Fang, X., & Maiti, A. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312661 · Cited by 56
“Firmicutes and Bacteriodes levels are increased in the intestinal microbiota of T1D patients, while they are reduced in T2D and obese patients [44,95].”
BackgroundGut microbiota and type 1 diabetes: a two-sample bidirectional Mendelian randomization study
Luo, M., Sun, M., Wang, T., Zhang, S., Song, X., Liu, X., Wei, J., Chen, Q., Zhong, T., & Qin, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1163898 · Cited by 65
“Studies evaluating the associations between the abundance of Actinobacteria and Proteobacteria and T1D exhibited inconsistent results, with positive, negative, and null associations all having been reported (Brown et al., 2011; Murri et al., 2013; Davis-Richardson et al., 2014; Leiva-Gea et al., 2018).”
ResultMenafra, D., Proganò, M., Tecce, N., Pivonello, R., & Colao, A. A. L. (2024) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2024.200286 · Cited by 52
Mechanistic insight into the gut microbiome and its interaction with host immunity and inflammation
Xue, J., Ajuwon, K. M., & Fang, R. (2020) · Animal nutrition · doi:10.1016/j.aninu.2020.05.007 · Cited by 54
Agarwal, S., Singh, V., & Chauhan, K. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2024130 · Cited by 61
Flavonoids and gastrointestinal health: single molecule for multiple roles
Lan, H., Wang, H., Chen, C., Hu, W., Ai, C., Chen, L., & Teng, H. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2230501 · Cited by 53
“…to the health of the host by Functional food added with proanthocyanidins animal reduce the number of tumor cells (Fernández et al. 2018) contributing to protein synthesis, lipogenesis, gluconeogenesis and enhancing the excretion of toxins (Brown et al. 2011; Louis and Flint 2017; Yan et al. 2019).”
The Computational Diet: A Review of Computational Methods Across Diet, Microbiome, and Health
Eetemadi, A., Rai, N., Pereira, B. M. P., Kim, M., Schmitz, H. H., & Tagkopoulos, I. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00393 · Cited by 55
“, 2018) or functional gene ontology terms (Brown et al., 2011).”
BackgroundRani, L., & Mondal, A. C. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.01.001 · Cited by 50
Li, J.-Z., Li, J., Wu, T., Xu, J., Huang, C., Cheng, D., Chen, Q., & Yu, T. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/5715403 · Cited by 52
“Moreover, abnormal enteric neuropathy caused by high blood sugar can modulate immune-cell function and stimulate proinflammatory cytokine production, resulting in neurodegeneration [26].”
BackgroundOmics-based biomarkers in the diagnosis of diabetes
Gan, W., Ramachandran, V., Lim, C. S. Y., & Koh, R. Y. (2019) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2019-0120 · Cited by 54
Qu, J., Zhao, Y. F., & Yin, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00291 · Cited by 49
“The most significant differences were noted in the genera Prevotella and Bacteroides (Brown et al., 2011).”
BackgroundInfluentialSu, S., Zhao, Y., Liu, Z., Liu, G., Du, M., Wu, J., Bai, D., Li, B., Bou, G., Zhang, X., et al. (2020) · MicrobiologyOpen · doi:10.1002/mbo3.1020 · Cited by 53
“The hindgut microbiota can produce a large amount of butyrate, which affects the health of the colonic mucosa (Brown et al., 2011; JalankaTuovinen et al., 2011; Pryde, Duncan, Hold, Stewart, & Flint, 2002).”
BackgroundHost-Microbe Interactions in Microgravity: Assessment and Implications
Foster, J. S., Wheeler, R. M., & Pamphile, R. (2014) · Life · doi:10.3390/life4020250 · Cited by 48
“Additionally, some species of bacteria within human gut have been recently correlated to the onset of several autoimmune diseases, such as rheumatoid arthritis and Type 1 diabetes [28–31]; colorectal cancers [32]; and obesity [33] suggesting that perturbations to the gut environment (e.”
BackgroundGenes and Gut Bacteria Involved in Luminal Butyrate Reduction Caused by Diet and Loperamide
Hwang, N., Eom, T.-K., Gupta, S. K., Jeong, S.-Y., Jeong, D., Kim, Y. S., Lee, J.-H., Sadowsky, M. J., & Unno, T. (2017) · Genes · doi:10.3390/genes8120350 · Cited by 47
“[13] suggested that optimal butyrate concentration in gut can be maintained by having abundant butyrate-producing bacteria and lactate-producing bacteria.”
BackgroundSex-dependent effects of bisphenol A on type 1 diabetes development in non-obese diabetic (NOD) mice
Xu, J., Huang, G., Nagy, T., Teng, Q., & Guo, T. L. (2019) · Archives of Toxicology · doi:10.1007/s00204-018-2379-5 · Cited by 49
Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity
Meng, X. L., Zhou, H., Shen, H., Lufumpa, E., Li, X., Guo, B., & Li, B. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.03.006 · Cited by 47
Ciężki, S., Kurpiewska, E., Bossowski, A. T., & Głowińska‐Olszewska, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.890833 · Cited by 60
“Decreased microbial diversity is believed to be associated with the T1D development, reported both in T1D patients (46) and in autoantibody-positive children (47).”
BackgroundPinto, E. S. L. C., Anselmo, M., Calha, M., Bottrill, A. R., Duarte, I., Andrew, P. W., & Faleiro, M. L. (2016) · Microbiology · doi:10.1099/mic.0.000412 · Cited by 46
Fernstrand, A. M., Bury, D., Garssen, J., & Verster, J. C. (2017) · Food & Nutrition Research · doi:10.1080/16546628.2017.1297053 · Cited by 49
Ren, M., Li, H., Fu, Z., & Li, Q. (2021) · Microorganisms · doi:10.3390/microorganisms9122524 · Cited by 47
Bélteky, M., Milletich, P. L., Ahrens, A. P., Triplett, E. W., & Ludvigsson, J. (2023) · Diabetologia · doi:10.1007/s00125-023-05895-7 · Cited by 50
Self-citationLin, K.-H., & Yu, Y. (2020) · Animals · doi:10.3390/ani10091649 · Cited by 45
“The Subdoligranulum genus is known to be involved in the conversion of lactate to butyrate and has been positively associated with feed efficiency in pigs [38,39].”
BackgroundFermentable fibres condition colon microbiota and promote diabetogenesis in NOD mice
Toivonen, R. K., Emani, R., Munukka, E., Rintala, A., Laiho, A., Pietilä, S., Pursiheimo, J., Soidinsalo, P., Linhala, M., Eerola, E., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3325-6 · Cited by 48
“In human studies, the potential association between Bacteroidetes-rich microbiota and progression to islet autoimmunity [24, 28, 32, 33] warrants consideration of these fibres in the diet of individuals at risk of developing type 1 diabetes.”
BackgroundResultInfluentialAdministration of defined microbiota is protective in a murine Salmonella infection model
Martz, S.-L. E., McDonald, J. A. K., Sun, J., Zhang, Y.-G., Gloor, G. B., Noordhof, C., He, S.-M., Gerbaba, T. K., Blennerhassett, M., Hurlbut, D. J., et al. (2015) · Scientific Reports · doi:10.1038/srep16094 · Cited by 43
Xu, J., Huang, G., Nagy, T., & Guo, T. L. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02419-4 · Cited by 47
Wang, L., Wang, Y., Li, H., Feng, X., Yuan, D., & Yang, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00684 · Cited by 44
“In addition, as pointed out by Christopher et al., microbiota that produces lactic acid and butyl hydrochloric acid such as Akkermansia and Prevotella can induce the synthesis of intestinal mucin, which may contribute to intestinal health (Brown et al., 2011).”
BackgroundThe gut microbiota in type 1 diabetes: friend or foe?
Gavin, P. G., & Hamilton‐Williams, E. E. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000483 · Cited by 46
Li, G., Liu, Z., Ren, F., Shi, H., Zhao, Q., Song, Y., Fan, X., Ma, X., & Qin, G. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.911992 · Cited by 52
Mruk-Mazurkiewicz, H., Kulaszyńska, M., Czarnecka, W., Podkówka, A., Ekstedt, N., Zawodny, P., Wierzbicka-Woś, A., Marlicz, W. M., Skupin, B., Stachowska, E., et al. (2024) · Nutrients · doi:10.3390/nu16111695 · Cited by 43
“…rich in butyrate producers leads to increased amounts of mucin, tighter junctions, and increased intergranularity of the intestinal barrier, thereby creating an attractive environment for the proliferation of A. muciniphila , whose abundance is significantly higher in healthy individuals [63,64].”
BackgroundImmuno-ecology: how the microbiome regulates tolerance and autoimmunity
Paun, A., & Danska, J. S. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.09.004 · Cited by 50
Conteville, L. C., Oliveira-Ferreira, J., & Vicente, A. C. P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01743 · Cited by 44
“In contrast, the urban-industrialized biomarkers produce SCFAs other than butyrate, such as propionate, acetate, and succinate, which, in high proportions, may increase gut permeability, leading to a further unhealthy status (Brown et al., 2011).”
BackgroundYang, J., Wang, T., Lin, G., Li, M., Zhu, R., Yiannikouris, A., Zhang, Y., & Mai, K. (2020) · Toxins · doi:10.3390/toxins12090597 · Cited by 42
“The present study showed that Diet 6 significantly decreased the abundance of some potential beneficial microbiota, including Lactobacillus, Lactococcus, Streptococcus, Faecalibacterium genera, which are lactic acid producers [93].”
BackgroundKahalehili, H. M., Newman, N. K., Pennington, J. M., Kolluri, S. K., Kerkvliet, N. I., Shulzhenko, N., Morgun, A., & Ehrlich, A. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.606441 · Cited by 53
“Consistent with dietary I3C increasing insulitis, there was a significant increase in the ratio of Bacteriodetes : Firmicutes at 12 weeks of age in mice fed the I3C supplemented diet (Figure 4D).”
BackgroundInfluentialSaha, S., Day-Walsh, P. E., Shehata, E., & Kroon, P. A. (2021) · Molecules · doi:10.3390/molecules26216444 · Cited by 48
“Short chain fatty acids (SCFAs), which include butyrate, propionate and acetate, are key metabolites produced by the gut microbiota from the fermentation of dietary fibre and resistant starch [4,5].”
BackgroundJeffery, N. D., Barker, A. K., Alcott, C. J., Levine, J. M., Meren, I. L., Wengert, J. A., Jergens, A. E., & Suchodolski, J. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170589 · Cited by 49
Roth‐Schulze, A. J., Penno, M. A. S., Ngui, K., Oakey, H., Bandala‐Sanchez, E., Smith, A. D., Allnutt, T. R., Thomson, R. L., Vuillermin, P., Craig, M. E., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01104-y · Cited by 44
Common ground: shared risk factors for type 1 diabetes and celiac disease
Verdu, E. F., & Danska, J. S. (2018) · Nature Immunology · doi:10.1038/s41590-018-0130-2 · Cited by 39
Sex bias in paediatric autoimmune disease – Not just about sex hormones?
Chiaroni-Clarke, R. C., Munro, J. E., & Ellis, J. A. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.02.011 · Cited by 47
Provotella-derived hydrogen sulfide, constipation, and neuroprotection in Parkinson's disease
Cakmak, Y. O. (2015) · Movement Disorders · doi:10.1002/mds.26258 · Cited by 37
“As the researchers stated, it has been shown that the Provotella abundance is positively associated with gut permeability.(7,8) Moreover, the researchers reported that increased gut permeability may lead to local and systemic exposure to bacterial endotoxins.”
BackgroundEarly-Life Nutritional Factors and Mucosal Immunity in the Development of Autoimmune Diabetes
Xiao, L., van’t Land, B., van de Worp, W. R. P. H., Stahl, B., Folkerts, G., & Garssen, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01219 · Cited by 36
“Mucin is well known as a glycoprotein produced by the host that is believed to contribute to gut integrity (17, 24).”
InfluentialLi, Z., Shan, Z., Xu, L., Fang, X., Wan, Y., Yu, D., & Guo, Y. (2022) · Food & Function · doi:10.1039/d2fo02678c · Cited by 38
Metabolic networks of the human gut microbiota
Selber‐Hnatiw, S., Sultana, T., Tse, W., Abdollahi, N., Abdullah, S., Rahbani, J. A., Alazar, D., Alrumhein, N. J., Aprikian, S., Arshad, R., et al. (2019) · Microbiology · doi:10.1099/mic.0.000853 · Cited by 41
The critical role of gut-brain axis microbiome in mental disorders
Basiji, K., Sendani, A. A., Ghavami, S. B., Farmani, M., Kazemifard, N., Sadeghi, A., Lotfali, E., & Aghdaei, H. A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01248-w · Cited by 58
“Reduction in Prevotellaceae in PD patients decreased the folate and thiamine biosynthesis and decreased the levels of beneficial neuroactive SCFAs which cause a lack of these vitamins in PD individuals (Brown et al. 2011 ).”
BackgroundHuman intestinal microbiome: Role in health and disease
Cantón, R., Ramos, P. D. L., Botella, A. G., García‐Lledó, A., Hernández‐Sampelayo, T., Gómez‐Pavón, J., del Castillo, J. M. G., Martín-Delgado, M. C., Martín‐Sánchez, F. J., Martínez‐Sellés, M., et al. (2024) · Revista Española de Quimioterapia · doi:10.37201/req/056.2024 · Cited by 40
Raine, T., Liu, J. Z., Anderson, C. A., Parkes, M., & Kaser, A. (2014) · Gut · doi:10.1136/gutjnl-2013-306657 · Cited by 40
Enteroendocrine Cells: Metabolic Relays between Microbes and Their Host
Plovier, H., & Cani, P. D. (2017) · Endocrine Development · doi:10.1159/000475736 · Cited by 36
Brown, C. T., Xiong, W., Olm, M. R., Thomas, B. C., Baker, R. W., Firek, B., Morowitz, M. J., Hettich, R. L., & Banfield, J. F. (2018) · mBio · doi:10.1128/mbio.00441-18 · Cited by 39
“However, 65 aberrations in this process may contribute to diseases such as type 1 and 2 diabetes, 66 irritable bowel disease, and necrotizing enterocolitis (NEC) in premature infants (6-11).”
BackgroundSelf-citationPhage Therapy: Beyond Antibacterial Action
Górski, A., Jończyk‐Matysiak, E., Międzybrodzki, R., Weber‐Dąbrowska, B., Łusiak-Szelachowska, M., Bagińska, N., Borysowski, J., Łobocka, M. B., Węgrzyn, A., & Węgrzyn, G. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00146 · Cited by 43
“For instance, comparative studies of metagenomic samples from patients with type 1 diabetes (T1D) and healthy individuals revealed significantly higher representation of phages and prophages in patients with this disorder, as compared to the control group (68).”
BackgroundMa, Y., & Yates, J. R. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1500902 · Cited by 37
“Another study illustrated that gut microbiomes may play a critical role in the pathological process of type 1 diabetes [67].”
BackgroundHe, B., Peng, L., & Li, Z. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02560 · Cited by 39
“0.001, Proteobacteria (2nd in the prediction list) was found to be higher in case samples than that in control samples (Brown et al., 2011).”
BackgroundInfluentialJia, E., Li, Z., Xue, Y.-F., Jiang, G., Li, X., Liu, W., & Zhang, D. (2017) · Aquaculture · doi:10.1016/j.aquaculture.2017.08.033 · Cited by 36
Yang, J., Wang, T., Lin, G., Li, M., Zhang, Y., & Mai, K. (2022) · Antioxidants · doi:10.3390/antiox11081492 · Cited by 39
Probiotics and Lactose Intolerance
Roel, J., Gerlof, A. R., Hermie, J. M., & Marion, G. (2012) · InTech eBooks · doi:10.5772/51424 · Cited by 37
“The hypothesis that for the prevention of diabetes type 1 butyrate production is preferred over propionate production is stated by [23].”
American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome
Semenkovich, C. F., Danska, J. S., Darsow, T., Dunne, J. L., Huttenhower, C., Insel, R. A., McElvaine, A. T., Ratner, R. E., Shuldiner, A. R., & Blaser, M. J. (2015) · Diabetes · doi:10.2337/db15-0597 · Cited by 40
BMCMDA: a novel model for predicting human microbe-disease associations via binary matrix completion
Shi, J., Huang, H., Zhang, Y., Cao, J.-B., & Yiu, S. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2274-3 · Cited by 37
“…an increasing number of clinical studies have demonstrated that the microbiota in human body is strongly associated with a wide range of human non-infectious diseases, such as cancer [9], obesity [10, 11], diabetes [12, 13], kidney stones [14] and systemic inflammatory response syndrome [15].”
BackgroundComparative analysis of the fecal microbiota from different species of domesticated and wild suids
Correa‐Fiz, F., Blanco-Fuertes, M., Navas, M. J., Lacasta, A., Bishop, R. P., Githaka, N., Onzere, C., Potier, M. L., Almagro, V., Martínez, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49897-1 · Cited by 40
Risk Factors for Type 1 Diabetes
Rewers, M., Stene, L. C., & Norris, J. M. (2018) · Europe PMC (PubMed Central) · Cited by 45
Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children
Torun, A., Hupalowska, A., Trzonkowski, P., Kierkuś, J., & Pyrzyńska, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642166 · Cited by 42
Tanaka, Y., Yamashita, R., Kawashima, J., Mori, H., Kurokawa, K., Fukuda, S., Gotoh, Y., Nakamura, K., Hayashi, T., Kasahara, Y., et al. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01888-2 · Cited by 41
“However, there were no significant differences in these SCFAs between HCs, IBS-n, and IBSs.”
BackgroundInfluentialWei, L., Ji, L., Miao, Y., Han, X., Li, Y., Wang, Z., Fu, J., Guo, L., Su, Y., & Zhang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115202 · Cited by 37
Sorini, C., & Falcone, M. (2013) · Europe PMC (PubMed Central) · Cited by 43
A Review of Applied Aspects of Dealing with Gut Microbiota Impact on Rodent Models
Hansen, A. K., Krych, Ł., Nielsen, D. S., & Hansen, C. H. F. (2015) · ILAR Journal · doi:10.1093/ilar/ilv010 · Cited by 38
“Both type 1 diabetic humans (Brown et al. 2011) and mice (Hansen, Krych et al. 2012; Nielsen et al. 2014) have fewer A. muciniphila.”
BackgroundJenkins, T. P., Pritchard, D. I., Tănăsescu, R., Telford, G., Papaiakovou, M., Scotti, R., Cortés, A., Constantinescu, C. S., & Cantacessi, C. (2021) · BMC Biology · doi:10.1186/s12915-021-01003-6 · Cited by 37
Enteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine
Drescher, K. M., von Herrath, M., & Tracy, S. (2014) · Reviews in Medical Virology · doi:10.1002/rmv.1815 · Cited by 37
“On these grounds then and despite the potential associations with T1D suppression, the use of helminths [114,115], whole bacteria [116,117], or extracts of bacteria [118,119] would be unacceptable without significantly more effort.”
BackgroundAdvances in Gut Microbiome Research, Opening New Strategies to Cope with a Western Lifestyle
Rodríguez-Castaño, G. P., Caro‐Quintero, A., Reyes, A., & Lizcano, F. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2016.00224 · Cited by 40
“Although not a single marker can be identified as representative of a healthy gut microbiome, a higher proportion of butyrate-producing and mucin-degrading bacteria has been mentioned in some studies (Brown et al., 2011; Joossens et al., 2011; Erickson et al., 2012).”
BackgroundFrom Disease and Patient Heterogeneity to Precision Medicine in Type 1 Diabetes
den Hollander, N. H. M., & Roep, B. O. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.932086 · Cited by 34
Huang, Y., Lou, X., Jiang, C., Ji, X., Tao, X., Sun, J., & Bao, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1044030 · Cited by 35
“The decreased abundance of SCFA-producing bacteria in fecal has been associated with an increased incidence of diabetes (37, 38).”
BackgroundZhang, W., Zhang, Y., Li, Y., Ma, D., Zhang, H., & Kwok, L. Y. (2022) · Nutrients · doi:10.3390/nu15010005 · Cited by 36
“It has been reported that brain cancer, breast cancer, lung cancer, and other tumor samples comprise tumor type-specific intracellular bacteria, localizing within both tumor and immune cells [4].”
Igudesman, D., Crandell, J. L., Corbin, K. D., Hooper, J., Thomas, J. M., Bulik, C. M., Pence, B. W., Pratley, R. E., Kosorok, M. R., Maahs, D. M., et al. (2023) · The Journal of Nutrition · doi:10.1016/j.tjnut.2022.12.017 · Cited by 32
Li, H., Wang, Y., Jiang, J., Zhao, H., Feng, X., Zhao, B., & Wang, L. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00676 · Cited by 32
“…a large number of human diseases are closely related to human microorganisms, including cancer (Moore and Moore, 1995), diabetes (Wen et al., 2008; Brown et al., 2011; Qin et al., 2012), Obesity (Ley et al., 2005; Zhang et al., 2009), kidney stones (Hoppe et al., 2011), and other thorny diseases.”
BackgroundFliegerova, K. O., Mahayri, T. M., Sechovcová, H., Mekadim, C., Mrázek, J., Jarošíková, R., Dubský, M., & Fejfarová, V. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1451054 · Cited by 41
“…Goffau et al., 2013; Leiva-Gea et al., 2018), Prevotella (Leiva-Gea et al., 2018), Blautia (Qi et al., 2016; Leiva-Gea et al., 2018), Veillonella (Brown et al., 2011; Leiva-Gea et al., 2018), Streptococcus (Brown et al., 2011; De Goffau et al., 2014; Leiva-Gea et al., 2018), Clostridium (Giongo…”
InfluentialRole of the microbiome in the normal and aberrant glycemic response
Suez, J., Shapiro, H., & Elinav, E. (2016) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2016.01.001 · Cited by 34
“One suggested mechanism for a causative antibiotic-diabetes link is antibiotic-mediated changes in microbiomemetabolism, leading to reduction of short chain fatty acids (SCFA), which may promote T1DM by increasing gut permeability [12].”
BackgroundSimões‐Silva, L., Araújo, R., Pestana, M., Soares‐Silva, I., & Sampaio‐Maia, B. (2020) · Microorganisms · doi:10.3390/microorganisms8020173 · Cited by 38
Pîrcălăbioru, G. G., Corcionivoschi, N., Gundogdu, O., Chifiriuc, M. C., Marutescu, L. G., Ispas, B., & Savu, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052763 · Cited by 35
“Some studies reported that alterations in microbiome composition were evident prior to T1DM development [27,28,36,55].”
BackgroundRoslund, M. I., Laitinen, O. H., & Sinkkonen, A. (2024) · People and Nature · doi:10.1002/pan3.10638 · Cited by 34
Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis
Leung, S. S., Forbes, J. M., & Borg, D. J. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0782-y · Cited by 32
Cao, J., Qin, L., Zhang, L., Wang, K., Yao, M., Qu, C., & Miao, J. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131214 · Cited by 30
Chi, C., Xue, Y., Liu, R., Wang, Y., Lv, N., Zeng, H., Buys, N. J., Zhu, B., Sun, J., & Yin, C. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02006-4 · Cited by 33
Simon, M., Reinbeck, A. L., Wessel, C., Heindirk, J., Jeleník, T., Kaul, K., Arreguín-Cano, J. A., Strom, A., Blaut, M., Bäckhed, F., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010816 · Cited by 33
“This finding corresponds to observations in patients with T1D and in children at increased risk for T1D showing a predominance of distinct Bacteroidetes species in their gut microbiome prior to the clinical onset of auto-immunity (21).”
BackgroundResultDong, J., Gao, H.-L., Wang, W., Yu, X., & Liu, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188484 · Cited by 31
Giampaoli, O., Conta, G., Calvani, R., & Miccheli, A. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.606171 · Cited by 37
“In particular, a reduction in butyrate-producing species was found in children with βcell autoimmunity (92).”
BackgroundCan type 1 diabetes be an unexpected complication of obesity?
Oboza, P., Ogarek, N., Olszanecka‐Glinianowicz, M., & Kocełak, P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1121303 · Cited by 38
“Furthermore, decreased microbial diversity was described in both T1D patients (31) and children with autoantibodies (32).”
BackgroundThe microbiology of human hygiene and its impact on type 1 diabetes
Chapman, N. M., Coppieters, K. T., von Herrath, M., & Tracy, S. (2012) · Islets · doi:10.4161/isl.21570 · Cited by 34
Sashinami, H., Asano, K., Yoshimura, S., Mori, F., Wakabayashi, K., & Nakane, A. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.09.022 · Cited by 33
Chicory Roots for Prebiotics and Appetite Regulation: A Pilot Study in Mice
Fouré, M., Dugardin, C., Foligné, B., Hance, P., Cadalen, T., Delcourt, A., Taminiau, B., Daube, G., Ravallec, R., Cudennec, B., et al. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01055 · Cited by 36
Noureldein, M. H., Nawfal, R., Bitar, S., Maxwell, S., Khurana, I., Kassouf, H. K., Khuri, F. R., El‐Osta, A., & Eid, A. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04485-x · Cited by 31
“Noteworthy, efforts to determine a microbial signature for diabetes have been confounded by the coexistence of obesity [47, 48].”
BackgroundGut microbiota interacts with inflammatory responses in acute pancreatitis
Wu, L., Hu, J., Yi, X.-L., Lv, J., Yao, J., Tang, W., Zhang, S., & Wan, M. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231202133 · Cited by 33
Ma, L., Zhang, L., Li, J., Zhang, X., Xie, Y., Li, X., Yang, B., & Yang, H. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00745-z · Cited by 36
“…(Demirci et al. 2020; Giongo et al. 2011), absence of butyrate producing bacteria, reduced bacterial diversity and community stability, which is significantly distinct from that of healthy individuals (Knip, and Siljander 2016; Brown et al. 2011; De Goffau et al. 2013; Kostic et al. 2015).”
BackgroundLung cancer progression alters lung and gut microbiomes and lipid metabolism
Hagihara, M., Kato, H., Yamashita, M., Shibata, Y., Umemura, T., Mori, T., Hirai, J., Asai, N., Mori, N., & Mikamo, H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23509 · Cited by 30
“…Among these bacterial species, showed significantly different relative abundance between the lung cancer and mock groups, Muribaculaceae consume mucin [32,33], Mucispirillum spp. Inhabit the mucin layer [34], and Roseburia spp. are butyrate-producing bacteria that promote mucin production [35,36].”
BackgroundTanca, A., Palomba, A., Fraumene, C., Manghina, V., Silverman, M. A., & Uzzau, S. (2018) · mSphere · doi:10.1128/msphere.00492-18 · Cited by 32
“The proportion of butyryl coenzyme A (butyryl-CoA) dehydrogenase genes was shown to be lower in the metagenomes of T1D cases than in those of healthy controls (12).”
BackgroundThe crucial role of early-life gut microbiota in the development of type 1 diabetes
Zhou, H., Sun, L., Zhang, S., Zhao, X. Y., Gang, X., & Wang, G. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01563-z · Cited by 33
“It has been demonstrated that these bacteria, in contrast with butyrate-producing species, would decrease the expression of TJ proteins and thus increase the gut permeability [13, 75].”
BackgroundZhang, S., Deng, F., Chen, J., Chen, F., Wu, Z., Li, L., & Hou, K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1075201 · Cited by 32
“It could protect the intestinal mucosal barrier function, enhance intestinal integrity, and reduce the chronic inflammatory state in diabetic patients (Brown et al., 2011).”
BackgroundOn the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota
Gianchecchi, E., & Fierabracci, A. (2016) · Immunologic Research · doi:10.1007/s12026-016-8832-8 · Cited by 32
“More specifically, the microbiome of the gut was characterized by a lower stability and diversity [182, 183], with a diverse ratio between Firmicutes and Bacteroidetes associated with reduced levels of Prevotella in T1D patients compared to controls [108, 182–185].”
ResultConsiderations When Designing a Microbiome Study: Implications for Nursing Science
Maki, K. A., Diallo, A. F., Lockwood, M. B., Franks, A. T., Green, S. J., & Joseph, P. V. (2018) · Biological Research For Nursing · doi:10.1177/1099800418811639 · Cited by 30
Zhang, C., Wang, Z., Liu, X., Liu, X., Liu, T., Feng, Y. Y., Yuan, Z., Jia, Z., & Zhang, Y. (2024) · iMeta · doi:10.1002/imt2.237 · Cited by 27
Do Bugs Control Our Fate? The Influence of the Microbiome on Autoimmunity
Fung, I. N., Garrett, J. P.-D., Shahane, A., & Kwan, M. (2012) · Current Allergy and Asthma Reports · doi:10.1007/s11882-012-0291-2 · Cited by 37
“found Actinobacteria, Bacteroidetes, and Proteobacteria were higher in T1D cases while Firmicutes, Fusobacteria, Tenericutes, and Verrucomicrobia were higher in controls subjects [63].”
BackgroundNew Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes
Cabello-Olmo, M., Araña, M., Radichev, I., Smith, P., Huarte, E., & Barajas, M. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194789 · Cited by 29
“In a related publication, the same research group provided further findings regarding the GM composition in the same sample [129].”
BackgroundResultInfluentialSimon, M., Reinbeck, A. L., Wessel, C., Heindirk, J., Jeleník, T., Kaul, K., Arreguín-Cano, J. A., Strom, A., Blaut, M., Bäckhed, F., et al. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49908-x · Cited by 32
Chapadgaonkar, S. S., Bajpai, S., & Godbole, M. S. (2023) · Cancer Reports · doi:10.1002/cnr2.1847 · Cited by 41
Metadata
- Authors
- Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., Veijola, R., Simell, T., Simell, O., Neu, J., Wasserfall, C. H., Schatz, D., Atkinson, M. A., & Triplett, E. W.
- Affiliations
- University of Florida (US)
- University of Eastern Finland (FI)
- University of Helsinki (FI)
- Tampere University Hospital (FI)
- University of Oulu (FI)
- Turku University Hospital (FI)
- Corresponding author
- Triplett, Eric W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-17
- Volume
- 6
- Issue
- 10
- Pages
- e25792
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3197175
- OpenAlex
- W2060915038
- Cited by
- 778
- References
- 48
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 53 · 2023: 60 · 2022: 69 · 2021: 73 · 2020: 66 · 2019: 69 · 2018: 68 · 2017: 59 · 2016: 55 · 2015: 49 · 2014: 47 · 2013: 38 · 2012: 22
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- type 1 diabetes, gut microbiota, autoimmunity, autoantibodies, metagenomics, bacterial gene function, carbohydrate metabolism, bacterial adhesion, flagella synthesis, butyrate production, short-chain fatty acids, mucin degradation, intestinal barrier integrity, lactate-utilizing bacteria, 16S rRNA
- MeSH terms
- Autoantibodies, Butyrates, Diabetes Mellitus, Type 1, Fatty Acids, Volatile, Humans, Mucins, RNA, Ribosomal, 16S, Autoimmunity, Case-Control Studies, Databases, Nucleic Acid, Gastrointestinal Tract, Metagenome, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.